Collaborative Bioprocessing: Next-Gen mAb Downstream Manufacturing Enhanced by Transcenta Partnership

WEBINAR

The bioprocessing industry has identified an urgent need to intensify downstream operations, making them smaller, faster, and more cost-effective. While numerous technologies and techniques exist to intensify individual unit operations, implementing an integrated next-generation bioprocess presents significant challenges. Our collaboration with Transcenta has culminated in the development of a state-of-the-art, highly automated bioprocessing train for the manufacture of monoclonal antibodies and other biologics.

This webinar will detail the bioprocessing template, operational paradigm, and the complexities involved in qualifying such an advanced manufacturing method.           

In this webinar, you will learn:

• What constitutes an intensified bioprocess,
• Transcenta's template for next-generation bioprocess capability,
• The installation and qualification of a multi-column chromatography system and a flow-through polishing system,
• Strategies for managing and qualifying long-duration bioprocessing challenges, such as bioburden control.